Precision Neuroscience was founded by Benjamin Rapoport and Michael Mager, both veterans of Neuralink. The company's Layer 7 Cortical Interface is a 1,024-electrode ECoG array delivered via a minimally invasive slit craniotomy — a strategic bet on surface recording rather than penetrating intracortical arrays. Precision's PATTERN I trial performs acute intraoperative recordings during elective neurosurgical procedures, accumulating safety and signal quality data en route to a chronic implant IDE. The company raised $93M in its Series C in 2024.